These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32789877)

  • 1. Pedicle flap coverage for infected ventricular assist device augmented with dissolving antibiotic beads: Creation of an antibacterial pocket.
    Still S; Myers RP; Tallaj J; Pamboukian S; Holman W; Davies J; Hoopes CW; Orozco-Hernandez E
    J Card Surg; 2020 Oct; 35(10):2825-2828. PubMed ID: 32789877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flap coverage for the treatment of exposed left ventricular assist device (LVAD) hardware and intractable LVAD infections.
    Jacoby A; Stranix JT; Cohen O; Louie E; Balsam LB; Levine JP
    J Card Surg; 2017 Nov; 32(11):732-737. PubMed ID: 29098712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex wound management in ventricular assist device (VAD) patients: the role of aggressive debridement and vascularized soft tissue coverage.
    Nelson JA; Shaked O; Fischer JP; Mirzabeigi MN; Jandali S; Kovach SJ; Low DW; Acker MA; Kanchwala SK
    Ann Plast Surg; 2014 Dec; 73 Suppl 2():S165-70. PubMed ID: 25393384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage of infected left ventricular assist device with antibiotic beads.
    Kretlow JD; Brown RH; Wolfswinkel EM; Xue AS; Hollier LH; Ho JK; Mallidi HR; Gregoric ID; Frazier OH; Izaddoost SA
    Plast Reconstr Surg; 2014 Jan; 133(1):28e-38e. PubMed ID: 24374685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorbable antibiotic beads as an adjuvant therapy in treating ventricular assist devices driveline infection: A case report.
    Haddad O; Pham AN; Thomas M; Ali M; Sareyyupoglu B; El-Sayed Ahmed MM; Pham SM
    J Card Surg; 2020 Aug; 35(8):2073-2076. PubMed ID: 32652630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flap Coverage of Infected Ventricular Assist Devices Influences Patient Outcomes.
    Sweitzer K; Butterfield J; Hubert J; Park W; Tomtschik J; Carter M; Gosev I; Bell D
    Ann Plast Surg; 2023 Jun; 90(6S Suppl 5):S552-S555. PubMed ID: 36729072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of left ventricular assist device erosion.
    Bartoli CR; Demarest CT; Khalpey Z; Takayama H; Naka Y
    J Card Surg; 2013 Nov; 28(6):776-82. PubMed ID: 24033369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
    Mourad A; Arif S; Bishawi M; Milano C; Miller RA; Maskarinec SA
    J Card Surg; 2020 Oct; 35(10):2672-2678. PubMed ID: 32678965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of muscle flaps to treat left ventricular assist device infections.
    Hutchinson OZ; Oz MC; Ascherman JA
    Plast Reconstr Surg; 2001 Feb; 107(2):364-73. PubMed ID: 11214051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device-related infections: a multicentric study.
    Siméon S; Flécher E; Revest M; Niculescu M; Roussel JC; Michel M; Leprince P; Tattevin P
    Clin Microbiol Infect; 2017 Oct; 23(10):748-751. PubMed ID: 28323195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plastic Surgery Involvement With Surgical Management of Infected Ventricular Assist Devices Decreased Lifetime Return to Operating Room and 90-Day Infectious Complications.
    Sweitzer K; Fowler C; Butterfield J; Visca A; Mayorga-Young D; Tomtschik J; Arias-Camison R; Bell D
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S200-S203. PubMed ID: 38556673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorbable antibiotic beads for treatment of LVAD driveline infections.
    Wadiwala I; Garg P; Alamouti-Fard E; Landolfo K; Sareyyupoglu B; Ahmed ME; Jacob S; Pham S
    Artif Organs; 2024 May; 48(5):559-566. PubMed ID: 38400624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escalating Surgical Treatment for Left Ventricular Assist Device Infection and Expected Mortality: Clinical Risk Prediction Score.
    Finnan MJ; Chi D; Chiang SN; Vader JM; Cabrera NL; Kells AF; Masood MF; Kotkar KD; Fox IK
    J Am Coll Surg; 2024 Sep; 239(3):263-275. PubMed ID: 38651731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over 870 days of successful antibiotic suppression therapy for VRE-infected left ventricular assist device.
    Radcliffe C; Grant M
    J Card Surg; 2020 Jul; 35(7):1746-1748. PubMed ID: 32557822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of an unusual complication associated with a HeartMate II LVAD in an adolescent.
    Echo A; Kelley BP; Bullocks JM; Morales DL
    Pediatr Transplant; 2012 Jun; 16(4):E130-3. PubMed ID: 21323825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omental and deep inferior epigastric artery perforator flap coverage after heart transplantation to manage wide left ventricular assist device exposure with pocket infection.
    Inatomi Y; Kadota H; Kaku K; Sonoda H; Tanoue Y; Shiose A
    J Artif Organs; 2018 Dec; 21(4):466-470. PubMed ID: 30349955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omental transposition flap for salvage of ventricular assist devices.
    Sajjadian A; Valerio IL; Acurturk O; Askari MA; Sacks J; Kormos RL; Manders EK
    Plast Reconstr Surg; 2006 Sep; 118(4):919-926. PubMed ID: 16980851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium chimaera left ventricular assist device infections.
    Balsam LB; Louie E; Hill F; Levine J; Phillips MS
    J Card Surg; 2017 Jun; 32(6):402-404. PubMed ID: 28508409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations and management of left ventricular assist device-associated infections.
    Nienaber JJ; Kusne S; Riaz T; Walker RC; Baddour LM; Wright AJ; Park SJ; Vikram HR; Keating MR; Arabia FA; Lahr BD; Sohail MR;
    Clin Infect Dis; 2013 Nov; 57(10):1438-48. PubMed ID: 23943820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.